InGel Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

InGel Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $350,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

InGel Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2022

SEC CIK1937613

What does InGel Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $350,000 sold (2022).

Frequently asked questions about InGel Therapeutics

Where is InGel Therapeutics headquartered?

InGel Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does InGel Therapeutics do?

InGel Therapeutics, Inc. is a biotechnology company.

When was InGel Therapeutics founded?

The earliest incorporation on record for InGel Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences